- Home
- SHO vs RCKT Comparison
SHO vs RCKT Comparison
Compare SHO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHO | RCKT |
|---|---|---|
| Founded | 1995 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 340.9M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHO | RCKT |
|---|---|---|
| Price | $9.15 | $3.55 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $9.31 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 2.2M | 2.0M |
| Earning Date | 11-07-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $937,930,000.00 | N/A |
| Revenue This Year | $5.75 | N/A |
| Revenue Next Year | $5.65 | N/A |
| P/E Ratio | $922.30 | ★ N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $7.45 | $2.19 |
| 52 Week High | $12.27 | $13.35 |
Technical Indicators
Market Signals| Indicator | SHO | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 56.13 |
| Support Level | $9.05 | $3.19 |
| Resistance Level | $9.33 | $3.57 |
| Average True Range (ATR) | 0.17 | 0.20 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 65.31 | 78.18 |
Price Performance
Historical ComparisonAbout SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.